ARCHIVES

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

MSK Issues Notice Of Dismissal To Neurosurgeon

September 8, 1995

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014

Decade-Long Cover-up?

January 6, 1995

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

CCOP Review Completed; 72 Applications Submitted, 23 More For Minority CCOP

December 1, 1989